l.trevino

TL2 Moderator · Genoa

Contributes reviews on supplier material. Based in Genoa.

Joined 3 January 2025 · last posted 3d

66 posts, newest first. Showing up to 150.

Documenting a supplier's response to a discrepancy Replied, post #48 · Sourcing › Vendor reports · 25 Jul 2026 · 32 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #118 · Evidence › Journal club · 19 Jul 2026 · 0 likes This follows post #115 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Programming during a large energy deficit Replied, post #38 · Nutrition & Training › Resistance training · 12 Jul 2026 · 15 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
Revisiting: The best-written scientific paper you have read Replied, post #86 · Lounge › Off topic · 12 Jul 2026 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
How shortages have affected compounding permissions Replied, post #30 · Access › Shortages · 11 Jul 2026 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
What to bring: records that a clinician can actually use — a second dataset Replied, post #7 · Clinical › Prescriber conversations · 4 Jul 2026 · 2 likes I read post #5 twice before replying, because I had assumed the opposite. Discussing off-label dosing: if you want to dose differently than the label specifies (slower…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #78 · Evidence › Journal club · 3 Jul 2026 · 11 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #10 · Practice › Dosing & titration · 3 Jul 2026 · 6 likes Worth separating two things that post #6 runs together. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea,…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #44 · Access › International · 29 Jun 2026 · 6 likes post #43 answers the question as asked. The question underneath it is different. Currency and exchange rates: paying in different currencies has different costs and…
Reading a home test result without over-claiming Replied, post #88 · Analytics › Home & field testing · 21 Jun 2026 · 10 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #92 · Practice › Reconstitution · 21 Jun 2026 · 24 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #51 · Analytics › Home & field testing · 16 Jun 2026 · 27 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
Injecting into an area that has become firm: why not to Replied, post #53 · Practice › Administration · 11 Jun 2026 · 17 likes This follows post #50 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #2 · Analytics › HPLC & UHPLC · 2 Jun 2026 · 2 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
Coming back to: A structured critique template this community uses Replied, post #24 · Evidence › Study critique · 2 Jun 2026 · 19 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Revisiting: What pooling buys you and what it destroys Replied, post #25 · Evidence › Meta-analyses · 17 May 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #105 · Devices › Syringes & needles · 10 May 2026 · 5 likes I read post #103 twice before replying, because I had assumed the opposite. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm…
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #2 · Clinical › Bloodwork · 5 May 2026 · 21 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #17 · Compounds › Oral incretins · 8 Apr 2026 · 4 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
Follow-up: Search filters: what is missing Replied, post #62 · Meta › Site feedback · 26 Mar 2026 · 23 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
Bioimpedance and hydration: why the number moves Replied, post #16 · Outcomes › Body composition · 10 Mar 2026 · 5 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
Grapefruit: why this class is not the class that cares Replied, post #3 · Practice › Interactions · 1 Mar 2026 · 1 like Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #109 · Practice › Interactions · 11 Feb 2026 · 8 likes On post #105 — agreed on the reasoning, with one qualification. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
When to stop reading forums, including this one Replied, post #82 · Wellbeing › Mental health · 28 Jan 2026 · 24 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Trifluoroacetate content and its consequences Replied, post #33 · Analytics › Impurities & related substances · 27 Jan 2026 · 3 likes This follows post #30 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #56 · Start Here › How to Ask · 25 Jan 2026 · 23 likes Coming back to post #54, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
What to include when your question involves a chromatogram Replied, post #53 · Start Here › How to Ask · 18 Jan 2026 · 1 like Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
Moderation log format change Replied, post #21 · Meta › Announcements · 13 Jan 2026 · 0 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
Reading an interaction checker output critically Replied, post #81 · Practice › Interactions · 1 Jan 2026 · 8 likes This follows post #78 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #99 · Analytics › COA interpretation · 28 Dec 2025 · 1 like When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
Prescription requirements and telehealth models Replied, post #70 · Sourcing › Regulatory · 16 Dec 2025 · 15 likes post #69 is right about the mechanism and I think understates the practical bit. Labelling and intended use: a compound sold as "research-use-only" does not change its…
When to stop reading forums, including this one Replied, post #61 · Wellbeing › Mental health · 13 Dec 2025 · 2 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #80 · Compounds › Oral incretins · 8 Dec 2025 · 10 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Substitution between formats during a shortage Replied, post #85 · Access › Shortages · 30 Oct 2025 · 9 likes Picking up post #82: that is the part I would want checked first. Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on…
Power cut for eleven hours: how I assessed it afterwards Replied, post #108 · Practice › Storage & stability · 23 Oct 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Reconciling a supplier certificate with an independent result Replied, post #5 · Sourcing › Vendor reports · 13 Oct 2025 · 0 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #80 · Analytics › HPLC & UHPLC · 23 Sep 2025 · 17 likes post #79 is right about the mechanism and I think understates the practical bit. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to…
Comparing my trajectory with the trial curves, carefully Replied, post #51 · Outcomes › Progress reports · 20 Sep 2025 · 0 likes I read post #49 twice before replying, because I had assumed the opposite. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration,…
Power cut for eleven hours: how I assessed it afterwards Replied, post #63 · Practice › Storage & stability · 19 Sep 2025 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #21 · Compounds › Tirzepatide · 16 Sep 2025 · 27 likes post #20 answers the question as asked. The question underneath it is different. Titration schedules for tirzepatide have more dose steps than semaglutide partly…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #51 · Compounds › Secretagogues & GH axis · 10 Aug 2025 · 17 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
Immortal time bias in a claims-database study Replied, post #9 · Evidence › Study critique · 29 Jul 2025 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A ten-fold dose error caught before injection Replied, post #69 · Devices › Syringes & needles · 22 Jul 2025 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #24 · Access › Insurance & coverage · 24 Jun 2025 · 0 likes On post #20 — agreed on the reasoning, with one qualification. Tier placement and step therapy: some formularies place a medication on a higher tier or require you to…
Half-life, steady state, and accumulation worked through Replied, post #90 · Pharmacology › Pharmacokinetics · 9 Jun 2025 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #9 · Evidence › Trials · 2 Jun 2025 · 3 likes post #8 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
Reading a trial's population section before its results — does this still hold? Replied, post #145 · Evidence › Trials · 25 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #38 · Clinical › Comorbidities · 22 May 2025 · 1 like This follows post #35 rather than contradicting it. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance.…
Triple agonism: additive, synergistic, or neither? Replied, post #45 · Compounds › Retatrutide · 12 May 2025 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Certificates issued by the seller versus by a laboratory Replied, post #20 · Analytics › COA interpretation · 27 Mar 2025 · 0 likes Picking up post #17: that is the part I would want checked first. When a document puts the specification in the result column, it has told you the release criterion,…
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #11 · Clinical › Bloodwork · 17 Mar 2025 · 27 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
Units, standards, and other things that quietly hold the world together Started this topic · Lounge › Off topic · 15 Mar 2025 · 34 likes Units, standards, and other things that quietly hold the world together — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but…
What changed in 2026, by region Replied, post #96 · Access › International · 24 Jan 2025 · 24 likes Picking up post #93: that is the part I would want checked first. Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #36 · Compounds › Secretagogues & GH axis · 15 Jan 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #142 · Practice › Dosing & titration · 5 Jan 2025 · 1 like Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
SURPASS-2 and the comparator dose question that will not go away Replied, post #81 · Compounds › Tirzepatide · 17 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Converting between mg/mL and units per dose, both directions Replied, post #128 · Practice › Reconstitution · 13 Dec 2024 · 15 likes post #127 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
Telehealth prescribing models in the US Replied, post #31 · Regional › North America · 8 Dec 2024 · 20 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #59 · Clinical › Prescriber conversations · 14 Nov 2024 · 17 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #63 · Analytics › Method validation · 31 Oct 2024 · 21 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #12 · Analytics › Method validation · 30 Sep 2024 · 15 likes Worth separating two things that post #8 runs together. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background.…
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #49 · Compounds › Retatrutide · 20 Sep 2024 · 3 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
A rising related-substance total over six months: degradation or method drift? Replied, post #28 · Analytics › Impurities & related substances · 2 Sep 2024 · 25 likes Coming back to post #26, because the follow-up matters more than the original answer. Truncation products: fragments from incomplete synthesis or from degradation. They…
When a red flag was a misunderstanding, and the retraction Replied, post #4 · Sourcing › Red flags · 18 Aug 2024 · 6 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
Why I ask for the gradient before I discuss the number Replied, post #6 · Analytics › HPLC & UHPLC · 10 Jul 2024 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
Spreadsheets: an appreciation Replied, post #7 · Lounge › Off topic · 5 Jun 2024 · 30 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.